Olinvacimab (Anti-VEGFR2 / KDR / CD309)
Product Specifications
CAS Number
2095504-49-5
Synonyms
TTAC-0001
SKU
C00711-1mg
Target
VEGFR
Applications
Protein Tyrosine Kinase
Additionnal Information
Olinvacimab (Anti-VEGFR2 / KDR / CD309) is a fully human monoclonal antibody targeting VEGFR2. It has antiangiogenic activity and can be used for the research of recurrent glioblastoma and breast cancer. MW :146.88 KD
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog